A PROSPECTIVE TRIAL OF TACROLIMUS (FK 506) IN CLINICAL HEART TRANSPLANTATION: INTERMEDIATE-TERM RESULTS

Between January 1, 1989, and December 31, 1994, we have treated 122 primary heart recipients with FK 506 (group I) and 121 with cyclosporine (group II). Fifty patients in the cyclosporine (CyA) group received no lympholytic induction (CyA alone) and 71 others received lympholytic induction with eith...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pham, Si M., Kormos, Robert L., Hattler, Brack G., Kawai, Akihiko, Tsamandas, Athanassios C., Demetris, Anthony J., Murali, Srinivas, Fricker, Frederick J., Chang, Huang C., Jain, Ashosk B., Starzl, Thomas E., Hardesty, Robert L., Griffith, Bartley P.
Format: Artigo
Idioma:Inglês
Publicat: 1996
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3022508/
https://ncbi.nlm.nih.gov/pubmed/8614136
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars